A phase II study of concurrent nab-paclitaxel/carboplatin combined with thoracic radiotherapy in locally advanced squamous cell lung cancer

BACKGROUND: The development of chemoradiotherapy is urgently needed for locally advanced squamous cell lung cancer due to its poor prognosis and significant toxicity. Carboplatin combined with nab-paclitaxel is a useful choice as first-line therapy in advanced squamous cell lung cancer. This prospec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Dis
Main Authors: Wu, Kan, Zhu, Lucheng, Wang, Jiahao, Pan, Kaicheng, Wang, Bing, Li, Xin, Yang, Shaoyu, Xu, Xiao, Zhang, Minna, Li, Xiadong, Chen, Xueqin, Ma, Shenglin, Xia, Bing
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2019
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6940262/
https://ncbi.nlm.nih.gov/pubmed/31903241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.10.81
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados